Market data chart with calculator
Markets

Celgene Makes Deal, Reports Earnings

Market data chart with calculator

Shutterstock photo

Celgene will pay up to $7 billion for Impact Biomedicines, which has an experimental treatment for a type of bone marrow cancer.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Other Topics

Stocks

Latest Markets Videos